✦ LIBER ✦

The xc−cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine

✍ Scribed by Jun Guan; Maisie Lo; Peter Dockery; Sarah Mahon; Cristina M. Karp; Arthur R. Buckley; Stephen Lam; Peter W. Gout; Yu-Zhuo Wang

Publisher: Springer
Year: 2008
Tongue: English
Weight: 373 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0894-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The x cystine/glutamate antiporter: A po

The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases

✍ Maisie Lo; Yu-Zhuo Wang; Peter W. Gout 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract The x cystine/glutamate antiporter is a major plasma membrane transporter for the cellular uptake of cystine in exchange for intracellular glutamate. Its main functions in the body are mediation of cellular cystine uptake for synthesis of glutathione essential for cellular protection fr

The x cystine/glutamate antiporter (xCT)

The x cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: Yet another cytotoxic anticancer approach?

✍ Nic E. Savaskan; Eric Hahnen; Ilker Y. Eyüpoglu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

## Abstract This article was published online on 4 May 2009. An error was subsequently identified. This notice is included in the online and print versions to indicate that both have been corrected 8 June 2009.

Response to Savaskan NE et al. “The x cy

Response to Savaskan NE et al. “The x cystine/glutamate antiporter—A potential target for therapy of cancer and other diseases: Yet another cytotoxic anticancer approach?”

✍ Maisie Lo; Yu-Zhuo Wang; Peter W. Gout 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

ErbB4 increases the proliferation potent

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy

✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with

Tumor response and progression-free surv

Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer : Findings on the basis of North Central Cancer Treatment Group trials

✍ Nathan R. Foster; Yingwei Qi; Qian Shi; James E. Krook; John W. Kugler; James R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views